Ly6/uPAR (LYNX; Ly6/neurotoxin) inhibitors represent a class of chemical compounds that modulate the function of proteins within the Ly6/uPAR family. This family is characterized by its distinctive three-fingered protein structure, reminiscent of snake and other animal neurotoxins, giving rise to the neurotoxin nomenclature. Ly6/uPAR proteins are predominantly glycosylphosphatidylinositol (GPI)-anchored to the cellular membrane, playing essential roles in various cellular signaling processes. These proteins are highly conserved across different species and exhibit significant biological diversity, acting primarily as modulators of extracellular signaling and protein-protein interactions. The inhibition of these proteins is of particular interest as they are involved in processes like cellular adhesion, migration, and signaling that are critical to both developmental biology and basic cellular homeostasis. By modulating how these proteins interact with their respective ligands or binding partners, inhibitors within this class offer a unique way to study the downstream effects of Ly6/uPAR family members on cellular function.
Structurally, Ly6/uPAR inhibitors are highly specific in their interaction with these proteins. The binding pockets or interaction surfaces on Ly6/uPAR proteins are often complex, requiring inhibitors to be precisely designed to target the three-finger structural motifs effectively. This specificity allows researchers to probe the biophysical properties of Ly6/uPAR interactions, revealing the intricate role these proteins play in cellular communication pathways. Beyond protein binding, Ly6/uPAR inhibitors may affect how GPI anchors attach these proteins to the cell membrane, offering additional avenues for exploration. By controlling or inhibiting these proteins' activities, researchers can explore the dynamic behaviors of signal transduction processes, protein localization, and cellular interaction networks that are central to understanding the role of Ly6/uPAR proteins in biological systems.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Amiloride • HCl | 2016-88-8 | sc-3578 sc-3578A | 25 mg 100 mg | $22.00 $56.00 | 6 | |
Known to inhibit uPAR-mediated cell adhesion and migration, commonly used in research focusing on cancer metastasis. | ||||||
Ciclopirox | 29342-05-0 | sc-217893 | 25 mg | $207.00 | 2 | |
An antifungal agent that has shown potential in inhibiting the function of uPA, thereby indirectly affecting uPAR. | ||||||
BC 11 hydrobromide | 443776-49-6 | sc-362712 sc-362712A | 10 mg 50 mg | $306.00 $1224.00 | ||
Known to inhibit uPA, and thus may indirectly affect uPAR functionality. | ||||||
GM 6001 | 142880-36-2 | sc-203979 sc-203979A | 1 mg 5 mg | $75.00 $265.00 | 55 | |
A broad-spectrum matrix metalloprotease inhibitor that can indirectly affect uPAR-mediated processes by altering the extracellular matrix environment. | ||||||
Rhosin | 1173671-63-0 | sc-507401 | 25 mg | $555.00 | ||
While primarily a Rho GTPase inhibitor, it may indirectly influence LU family members due to their involvement in cell adhesion and motility. | ||||||